Abiomed
Abiomed® is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology.
External Program
Submit bugs directly to this organization
Abiomed
Abiomed® is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology.
External Program
Submit bugs directly to this organization
In support of post-market cybersecurity management activities, Abiomed participates in the MedISAO vulnerability disclosure process. MedISAO is a U.S. Food and Drug Administration (FDA) recognized Information Sharing and Analysis Organization (ISAO) and provides reporting mechanisms for individuals who have discovered potential vulnerabilities in products.
At Abiomed, we believe in our Patients First mission and are committed to fully integrating cybersecurity into the products we provide and the processes we follow.
If you believe you have identified a potential vulnerability in any Abiomed medical device, medical device data system, or software as a medical device solution, please submit information related to the potential vulnerability using the MedISAO vulnerability reporting form.